Retrospective Study
Copyright ©The Author(s) 2024.
World J Clin Oncol. Jun 24, 2024; 15(6): 745-754
Published online Jun 24, 2024. doi: 10.5306/wjco.v15.i6.745
Table 1 Demographic and Clinicopathologic characteristics of United States patients with hepatosplenic T-cell lymphoma between 2000 and 2017
Characteristics
n
%
Total186100
Gender
    Female58 31.18
    Male 128 68.82
Age at diagnosis, yr
    0-3963 33.87
    40-5967 36.02
    60-7944 23.66
    80+12 6.45
Race
    Non-Hispanic white113 60.75
    Non-Hispanic black39 20.97
    Hispanic158.06
    Other19 10.22
Tumor stage
    Localized44 23.66
    Regional13 6.99
    Distant129 69.35
Living area
    Counties in metropolitan areas of 1 million persons11863.44
    Counties in metropolitan areas of 250000 to 1 million persons 38 20.43
    Counties in metropolitan areas of 250000 persons17 9.14
    Nonmetropolitan counties13 6.99
Income per year
    $ < $550002211.83
    $55000-6499933 17.74
    $65000-7499945 24.19
    $75000+86 46.24
Marital status
    Married8244.09
    Single/unknown7841.94
    Divorced/separated147.53
    Widowed126.45
Radiation
    No17393.01
    Yes 136.99
Surgery
    No116 62.37
    Yes70 37.63
B symptoms
    No12265.59
    Yes 64 34.41
Year of diagnosis
    20001 0.54
    200163.23
    20025 2.69
    2003115.91
    200410 5.38
    20055 2.69
    2006115.91
    200773.76
    200884.30
    2009126.45
    2010115.91
    2011147.53
    2012105.38
    2013168.60
    2014126.45
    2015147.53
    2016147.53
    201719 10.22
Table 2 Crude analysis of factors associated with all-cause mortality and hepatosplenic T-cell lymphoma mortality among patients between 2000 and 2017
Characteristics
Overall mortality crude proportional hazard ratio (95% confidence interval)
HSTCL crude proportional hazard ratio (95% confidence interval)
Gender
    Female1 (reference) 1 (reference)
    Male 0.96 (0.65-1.39)0.99 (0.65-1.52)
Age at diagnosis, yr
    0-391 (reference)1 (reference)
    40-590.80 (0.53-1.22)0.69 (0.44-1.11)
    60-790.95 (0.59-1.54)0.85 (0.50-1.45)
    80+1.60 (0.68-3.77)1.44 (0.57-3.65)
Race
    Non-Hispanic white1 (reference)1 (reference)
    Non-Hispanic black1.97 (1.27-3.07)b2.34 (1.47-3.72)b
    Hispanic1.44 (0.71-2.89)1.41 (0.64-3.13)
    Other1.65 (0.96-2.86)1.62 (0.86-3.04)
Tumor stage
    Localized1 (reference) 1 (reference)
    Regional1.28 (0.57-2.86)1.63 (0.62-4.30)
    Distant1.54 (0.97-2.43)2.23 (1.24-4.02)b
Living area
    Counties in metropolitan areas of 1 million persons1 (reference) 1 (reference)
    Counties in metropolitan areas of 250000 to 1 million persons0.73 (0.46-1.16)0.69 (0.41-1.17)
    Counties in metropolitan areas of 250000 persons1.19 (0.63-2.24)1.02 (0.49-2.12)
Nonmetropolitan counties1.43 (0.76-2.70)1.22 (0.59-2.56)
Income per year
    $ < $550001 (reference)1 (reference)
    $55000-649991.26 (0.65-2.45)1.39 (0.65-2.99)
    $65000-749991.18 (0.63-2.20)1.25 (0.59-2.61)
    $75000+0.82 (0.45-1.49)1.02 (0.51-2.03)
Marital status
    Married1 (reference)1 (reference)
    Single/unknown1.12 (0.76-1.64)1.32 (0.86-2.04)
    Divorced/separated1.49 (0.8-2.85)1.77 (0.88-3.56)
    Widowed1.98 (0.89-4.38)1.82 (0.72-4.65)
Radiation
    No1 (reference)1 (reference)
    Yes0.77 (0.37-1.58)0.81 (0.38-1.75)
Surgery
    No1 (reference) 1 (reference)
    Yes 0.76 (0.53-1.09)0.72 (0.48-1.09)
B symptoms
    No1 (reference) 1 (reference)
    Yes 1.23 (0.85-1.80)1.14 (0.75-1.75)
Table 3 Multivariate cox proportional hazard regression analyses of factors affecting all-cause mortality and hepatosplenic T-cell lymphoma related mortality among patients between 2000 and 2017
Characteristics
Overall mortality adjusted proportional hazard ratio (95% confidence interval)
HSTCL adjusted proportional hazard ratio (95% confidence interval)
Gender
    Female1 (reference) 1 (reference)
    Male 0.79 (0.48-1.29)0.83 (0.49-1.41)
Age at diagnosis, yr
    0-391 (reference)1 (reference)
    40-590.60 (0.32-1.13)0.62 (0.30-1.26)
    60-791.32 (0.67-2.58)1.65 (0.78-3.49)
    80+2.98 (0.88-10.09)4.72 (1.14-19.54)a
Race
    Non-Hispanic white 1 (reference)1 (reference)
    Non-Hispanic black1.61 (0.89-2.89)2.02 (1.08-3.79)a
    Hispanic 1.87 (0.73-4.78)1.90 (0.69-5.28)
    Other 1.59 (0.79-3.19)1.49 (0.67-3.37)
Tumor stage
    Localized 1 (reference) 1 (reference)
    Regional 0.69 (0.24-2.01)1.17 (0.33-4.19)
    Distant 1.03 (0.57-1.87)1.85 (0.87-3.89)
Living area
    Counties in metropolitan areas of 1 million persons1 (reference)1 (reference)
    Counties in metropolitan areas of 250,000 to 1 million persons1.19 (0.69-2.07)1.05 (0.55-2.02)
    Counties in metropolitan areas of 250000 persons1.07 (0.44-2.60)0.68 (0.24-1.94)
    Nonmetropolitan counties2.71 (0.78-9.39)2.36 (0.50-11.09)
Income per year
    $ < $550001 (reference) 1 (reference)
    $55000-649992.72 (0.82-9.07)2.54 (0.58-11.08)
    $65000-749991.75 (0.53-5.85)1.04 (0.23-4.63)
    $75000+1.46 (0.43-4.96)1.23 (0.28-5.53)
Marital status
    Married1 (reference)1 (reference)
    Single/unknown 0.83 (0.48-1.44)0.94 (0.51-1.75)
    Divorced/separated 1.33 (0.61-2.90)1.79 (0.77-4.19)
Widowed 1.19 (0.39-3.62)1.01 (0.26-3.87)
Radiation
    No1 (reference) 1 (reference)
    Yes0.86 (0.35-2.10)1.07 (0.38-3.01)
Surgery
    No1 (reference) 1 (reference)
    Yes 0.83 (0.49-1.40)0.97 (0.54-1.76)
B symptoms
    No1 (reference)1 (reference)
    Yes 1.66 (0.85-3.24)2.21 (0.99-4.89)

  • Citation: Bangolo A, Fwelo P, Dey S, Sethi T, Sagireddy S, Chatta J, Goel A, Nagpaul S, Chen EPS, Saravanan C, Gangan S, Thomas J, Potiguara S, Nagesh VK, Elias D, Mansour C, Ratnaparkhi PH, Jain P, Mathew M, Porter T, Sultan S, Abbisetty S, Tran L, Chawla M, Lo A, Weissman S, Cho C. Characteristics and distinct prognostic determinants of individuals with hepatosplenic T-cell lymphoma over the past two decades. World J Clin Oncol 2024; 15(6): 745-754
  • URL: https://www.wjgnet.com/2218-4333/full/v15/i6/745.htm
  • DOI: https://dx.doi.org/10.5306/wjco.v15.i6.745